SANOFI-AVENTIS (EPA:SAN) | Finanzwire

Basculer en Français

11118	Companies
244805	Keywords
172884	Articles
131993	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 12/23/2025 at 07:00, 9 months 11 days ago

Press Release: Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma
Sanofi and Regeneron's Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma, showing significant reduction in exacerbations and improved lung function in phase 3 studies

Sanofi Phase 3 Study Dupixent Regeneron Bronchial Asthma
BRIEF

published on 12/22/2025 at 18:40, 9 months 11 days ago

Sanofi Provides Update on Voting Rights and Shares for November 2025

Voting Rights Treasury Shares Issued Shares Sanofi November 2025
PRESS RELEASE

published on 12/22/2025 at 18:35, 9 months 11 days ago

Sanofi: Information concerning the total number of voting rights and shares - November 2025
Sanofi discloses total voting rights and shares under French regulations. Details available on website. Contact Investor Relations Department for more information

Voting Rights Shares French Regulations Investor Relations Sanofi
BRIEF

published on 12/19/2025 at 20:26, 9 months 14 days ago

Sanofi Agreement with US Government to Lower Medicine Costs

Innovation Healthcare Savings US Government Sanofi Agreement Medicine Costs
BRIEF

published on 12/19/2025 at 20:26, 9 months 14 days ago

Sanofi signs an agreement with the United States to reduce the cost of medicines

Biopharmaceutical Innovation Sanofi Affordable Medications Trump Deal Investments In The United States
PRESS RELEASE

published on 12/19/2025 at 20:21, 9 months 14 days ago

Press Release: Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation
Sanofi agrees with US government to lower medicine costs, support innovation, and US manufacturing. Agreement meets President Trump's requests, ensuring affordable access for American patients

Innovation Manufacturing Sanofi US Government Medicine Costs
BRIEF

published on 12/17/2025 at 07:35, 9 months 17 days ago

Sanofi publishes the document "Q4 2025 Quick Reference Guide"

Financial Results Investors Sanofi Q4 2025 Modeling
BRIEF

published on 12/17/2025 at 07:35, 9 months 17 days ago

Sanofi Releases Q4 2025 Aide Mémoire

Sanofi Financial Modeling Aide Mémoire Q4 2025 Forward-Looking
PRESS RELEASE

published on 12/17/2025 at 07:30, 9 months 17 days ago

Press release: Availability of the Q4 2025 Aide memoire
Sanofi announces availability of Q4 2025 Aide memoire on the company's website for financial modeling purposes. Q4 2025 results to be published on January 29, 2026

Sanofi Results Aide Mémoire Financial Modelling Q4 2025
BRIEF

published on 12/15/2025 at 07:10, 9 months 19 days ago

Sanofi Halts Pursuit of Regulatory Registration for Tolebrutinib in PPMS

Multiple Sclerosis Tolebrutinib PPMS Trial PERSEUS Study Sanofi R&D

Accesswire

Published on 10/03/2026 at 02:35, 15 hours 43 minutes ago

Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 17:45, 1 day ago

Sparton Provides Status Update
Published on 10/02/2026 at 13:50, 1 day 4 hours ago

AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 1 day 5 hours ago

Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 1 day 5 hours ago

Alaska Energy Metals Appoints Independent Director, Thomas Benson

View all ACCESSWIRE

EQS Group

Published on 10/03/2026 at 15:45, 2 hours 33 minutes ago

Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Published on 10/02/2026 at 23:55, 18 hours 23 minutes ago

IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 21 hours 54 minutes ago

EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Published on 10/02/2026 at 19:46, 22 hours 32 minutes ago

innoscripta SE: Update on the Tax Authorities’ Investigation – Business Operations Continue as Usual – Full Transparency Assured – Invitation to Shareholders for an In-Person Product Presentation
Published on 10/02/2026 at 18:00, 1 day ago

EQS-Adhoc: AMUNDI PHYSICAL GOLD ETC (the “ETC”): Release of the first Supplemental Base Prospectus (the “Supplemental”)

Les Echos

Published on 10/02/2026 at 17:45, 1 day ago

Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:30, 1 day ago

Aéroports de Paris SA - 2027 Financial Calendar
Published on 10/01/2026 at 19:00, 1 day 23 hours ago

AMA CORP PLC reduces its cost base while preserving XpertEye’s key functions
Published on 10/01/2026 at 18:40, 1 day 23 hours ago

Monthly disclosure of the total number of shares and voting rights - September 2026
Published on 10/01/2026 at 18:05, 2 days ago

Covivio - Information on total number of voting rights and share capital

View all LES ECHOS COMFI WIRE